Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Biopharmaceutical Research Company

Clinical trials sponsored by Biopharmaceutical Research Company, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Cannabis-Based drug BRC-002 enters first human safety trials Results expected Oct 2026 (estimated)

Browse trials soon ready across all sponsors →

Not yet finished but already full! 1

Cannabis-Based drug BRC-002 enters first human safety trials

Knowledge-focused By invitation only

This phase 1 study evaluates the safety and tolerability of BRC-002, an investigational cannabis-derived botanical drug, in healthy adults aged 18 to 55. Researchers will also examine how the body processes the drug and whether food affects its absorption. The results will guide …

Phase 1 • Sponsor: Biopharmaceutical Research Company • Aim: Knowledge-focused

Last updated Jul 15, 2026 00:00 UTC